Literature DB >> 12115390

Adenosquamous carcinoma of the gallbladder warrants resection only if curative resection is feasible.

Yasuhiro Oohashi1, Yoshio Shirai, Toshifumi Wakai, Shigenori Nagakura, Hidenobu Watanabe, Katsuyoshi Hatakeyama.   

Abstract

BACKGROUND: Adenosquamous/squamous cell carcinoma of the gallbladder generally has been considered a lethal disease. The objective of this study was to clarify the effectiveness of resection for patients with adenosquamous/squamous cell carcinoma of the gallbladder.
METHODS: Twenty-nine patients who underwent resection for either adenosquamous carcinoma (n = 28 patients) or squamous cell carcinoma (n = 1 patient) were analyzed retrospectively. Sixteen patients underwent radical resection, whereas the other patients underwent primary tumor resection alone. To elucidate the factors that influenced postresectional survival, 10 variables (age, gender, presence or absence of gallstones, size of the primary tumor, lymphatic vessel invasion, blood vessel invasion, perineural invasion, TNM stage, residual tumor status, and type of resection) were examined.
RESULTS: Twenty-three patients (79.3%) were categorized with T3 or T4 tumors that invaded adjacent organs. The outcome after undergoing radical resection (cumulative 5-year survival rate, 48.6%) was significantly better compared with the outcome of patients after undergoing primary tumor resection alone (cumulative 3-year survival rate, 7.7%; P = 0.004). The outcome after undergoing resection was better in 14 patients who had no residual tumor (cumulative 5-year survival rate, 62.9%) compared with the outcome in 15 patients who had residual tumor (cumulative 5-year survival rate, 0%; P < 0.001). Univariate analysis revealed that residual tumor status (P < 0.001), type of resection (P = 0.004), patient age (P = 0.012), and blood vessel invasion (P = 0.017) were significant prognostic factors. Residual tumor status (P = 0.026) was the only significant independent prognostic factor.
CONCLUSIONS: Adenosquamous/squamous cell carcinoma of the gallbladder warrants resection only if potentially curative (R0) resection is feasible. Copyright 2002 American Cancer Society.

Entities:  

Mesh:

Year:  2002        PMID: 12115390     DOI: 10.1002/cncr.10578

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  18 in total

1.  Ruptured adenosquamous cell carcinoma of the gallbladder: case report and review of literature.

Authors:  Tarun Rustagi; Mridula Rai; Mohanakrishnan Menon
Journal:  Gastrointest Cancer Res       Date:  2011-01

2.  Adjuvant chemoradiotherapy for squamous cell carcinoma of gallbladder.

Authors:  Supriya Mallick; Rony Benson; P K Julka; Goura Kishor Rath
Journal:  J Gastrointest Cancer       Date:  2014-12

3.  Squamous Cell and Adenosquamous Carcinoma of Gall Bladder: a Clinicopathological Study of 8 Cases Isolated in 94 Cancers.

Authors:  Hanni Vasudev Gulwani; Suneeta Gupta; Sukhpreet Kaur
Journal:  Indian J Surg Oncol       Date:  2017-05-03

4.  Comparative Outcomes of Adenosquamous Carcinoma of the Gallbladder: an Analysis of the National Cancer Database.

Authors:  Gilbert Murimwa; Caitlin Hester; John C Mansour; Patricio M Polanco; Matthew R Porembka; Sam C Wang; Herbert J Zeh; Adam C Yopp
Journal:  J Gastrointest Surg       Date:  2020-07-23       Impact factor: 3.452

5.  Prothymosin-α and parathymosin expression predicts poor prognosis in squamous and adenosquamous carcinomas of the gallbladder.

Authors:  Kang Chen; Li Xiong; Zhuling Yang; Shengfu Huang; Rong Zeng; Xiongying Miao
Journal:  Oncol Lett       Date:  2018-01-19       Impact factor: 2.967

6.  A Case Report on Adenosquamous Carcinoma of Gallbladder: A Very Rare Malignancy.

Authors:  Shobha Mandal; Sravan K Ponnekanti; Chandrakala Dadeboyina; Anusha Tipparthi; Vineela Kasireddy
Journal:  Cureus       Date:  2021-06-21

7.  A comparative study of clinicopathological significance, FGFBP1, and WISP-2 expression between squamous cell/adenosquamous carcinomas and adenocarcinoma of the gallbladder.

Authors:  Zhulin Yang; Zhi Yang; Qiong Zou; Yuan Yuan; Jinghe Li; Daiqiang Li; Lufeng Liang; Guixiang Zeng; Senlin Chen
Journal:  Int J Clin Oncol       Date:  2013-04-17       Impact factor: 3.402

8.  Combined major hepatectomy and pancreaticoduodenectomy for locally advanced biliary carcinoma: long-term results.

Authors:  Toshifumi Wakai; Yoshio Shirai; Yoshiaki Tsuchiya; Tatsuya Nomura; Kouhei Akazawa; Katsuyoshi Hatakeyama
Journal:  World J Surg       Date:  2008-06       Impact factor: 3.352

9.  The Expression of Notch 1 and Notch 3 in Gallbladder Cancer and Their Clinicopathological Significance.

Authors:  Luyao Liu; Zhu-Lin Yang; Chunwei Wang; Xiongying Miao; Zhiyu Liu; Daiqiang Li; Qiong Zou; Jinghe Li; Lufeng Liang; Guixiang Zeng; Senlin Chen
Journal:  Pathol Oncol Res       Date:  2015-12-03       Impact factor: 3.201

10.  Clinicopathological features and CCT2 and PDIA2 expression in gallbladder squamous/adenosquamous carcinoma and gallbladder adenocarcinoma.

Authors:  Qiong Zou; Zhu-lin Yang; Yuan Yuan; Jing-he Li; Lu-feng Liang; Gui-xiang Zeng; Sen-lin Chen
Journal:  World J Surg Oncol       Date:  2013-06-19       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.